EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

The Impact of Antenatal Azithromycin and Monthly Sulfadoxine-Pyrimethamine on Maternal Malaria during Pregnancy and Fetal Growth: A Randomized Controlled Trial

Lotta Hallamaa, Per Ashorn, Yin Bun Cheung, Mari Luntamo, Ulla Ashorn, Teija Kulmala, Kenneth Maleta, Charles Mangani, Yue-Mei Fan

The American Journal of Tropical Medicine and Hygiene · 2023

DOI: 10.4269/ajtmh.22-0496 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift The American Journal of Tropical Medicine and Hygiene, 2023. Verfasst von Lotta Hallamaa und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center for Child, Adolescent and Maternal Health Research, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland. Hauptthemen laut MEDLINE: Pregnancy Complications, Parasitic, Malaria, Antimalarials. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Maternal malaria and infections during pregnancy are risk factors for fetal growth restriction. We assessed the impact of preventive treatment in pregnancy on maternal malaria and fetal growth. Between 2003 and 2006, we enrolled 1,320 pregnant Malawian women, 14–26 gestation weeks, in a randomized trial and treated them with two doses of sulfadoxine-pyrimethamine (SP, control) at enrollment and between 28–34 gestation weeks; with monthly SP from enrollment until 37 gestation weeks; or with monthly SP and azithromycin twice, at enrollment and between 28 and 34 gestation weeks (AZI-SP). Participants were seen at 4-week intervals until 36 completed gestation weeks and weekly thereafter. At each visit, we collected dried blood spots for real-time polymerase chain reaction diagnosing of malaria parasitemia and, in a random subgroup of 341 women, we measured fetal biparietal diameter and femur length with ultrasound. For the monthly SP versus the control group, the odds ratios (OR) (95% CI) of malaria parasitemia during the second, third, and both trimesters combined were 0.79 (0.46–1.37), 0.58 (0.37–0.92), and 0.64 (0.42–0.98), respectively. The corresponding ORs for the AZI-SP versus control group were 0.47 (0.26–0.84), 0.51 (0.32–0.81), and 0.50 (0.32–0.76), respectively. Differences between the AZI-SP and the monthly SP groups were not statistically significant. The interventions did not affect fetal biparietal diameter and femur length growth velocity. The results suggest that preventive maternal treatment with monthly SP reduced malaria parasitemia during pregnancy in Malawi and that the addition of azithromycin did not provide much additional antimalarial effect.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pregnancy Complications, ParasiticMalariaAntimalarialsFemalePregnancyHumansAzithromycinParasitemiaPyrimethamineDrug CombinationsFetal DevelopmentSulfadoxine

Substanzen

AzithromycinPyrimethamineAntimalarialsDrug Combinationsfanasil, pyrimethamine drug combinationSulfadoxine

Autor:innen und Institutionen

  • Center for Child, Adolescent and Maternal Health Research, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
  • Department of Pediatrics, Tampere University Hospital, Tampere, Finland.
  • Centre for Quantitative Medicine, Duke-NUS Medical School, Singapore.
  • Department of Public Health, School of Global and Public Health, Kamuzu University of Health Sciences, Blantyre, Malawi.

Zitieren

APA

Hallamaa, L., Ashorn, P., Cheung, Y. B., Luntamo, M., Ashorn, U., Kulmala, T., Maleta, K., Mangani, C., & Fan, Y. M. (2023). The Impact of Antenatal Azithromycin and Monthly Sulfadoxine-Pyrimethamine on Maternal Malaria during Pregnancy and Fetal Growth: A Randomized Controlled Trial. The American Journal of Tropical Medicine and Hygiene. https://doi.org/10.4269/ajtmh.22-0496

Vancouver

Hallamaa L, Ashorn P, Cheung YB, Luntamo M, Ashorn U, Kulmala T, et al. The Impact of Antenatal Azithromycin and Monthly Sulfadoxine-Pyrimethamine on Maternal Malaria during Pregnancy and Fetal Growth: A Randomized Controlled Trial. The American Journal of Tropical Medicine and Hygiene. 2023. doi:10.4269/ajtmh.22-0496

BibTeX
@article{Hallamaa2023,
  author = {Hallamaa, Lotta and Ashorn, Per and Cheung, Yin Bun and Luntamo, Mari and Ashorn, Ulla and Kulmala, Teija and Maleta, Kenneth and Mangani, Charles and Fan, Yue-Mei},
  title = {The Impact of Antenatal Azithromycin and Monthly Sulfadoxine-Pyrimethamine on Maternal Malaria during Pregnancy and Fetal Growth: A Randomized Controlled Trial},
  journal = {The American Journal of Tropical Medicine and Hygiene},
  year = {2023},
  doi = {10.4269/ajtmh.22-0496}
}
Kostenlos starten →